10+ can't-miss Houston business and innovation events for March

Where to be

Here's your one-stop shop for innovation events in Houston this month. Photo via Getty Images

Saddle up, y'all. March might be the city of Houston's busiest month. The Houston Livestock Show and Rodeo has kicked off, as has Houston Tech Rodeo. Plus, Houston innovators have CERAWeek to look forward to, as well as Houston-focused activations in Austin at SXSW. Here's a rundown of what all to throw on your calendar this month.

This article will be updated as more business and tech events are announced.


February 27-March 5 — Houston Tech Rodeo

Houston Exponential returns with its 3rd annual Houston Tech Rodeo, a week of events showcasing and connecting Houston's innovation and tech ecosystem. The majority of the programming is taking place downtown, and all events are free to attend. Click here to browse this year's events upon registration.

Click here for five can't-miss HTR events.

Click here to learn more about HTR.

March 2 — Building a Startup Ecosystem to Support Asian American Entrepreneurs

FilKor Capital's mission is to empower resilient Asian Americans to build enduring companies. We are focused on underserved communities to build deep and systemic impact, starting with Filipino American and Korean Americans. This event will launch a listening tour with a diverse mix of stakeholders (entrepreneurs, funders, government, chambers, corporates, universities, community, etc.) to understand needs, opportunities and ways to engage.

The event is Wednesday, March 2, from noon to 2 pm at Impact Hub Houston (1801 Main St.). Click here to register.

March 2 — Beyond the Pitch Deck

Pitching successfully is more than just creating a deck. Founders get a lot of advice on how to put slides together — but how do investors actually approach the process of determining what companies they want to invest in? In this moderated panel, founders can hear directly from investors to understand their perspectives.

The event is Wednesday, March 2, from 1 to 3 pm at Cannon West Houston (1334 Brittmoore Road). Click here to register.

March 3 — Ignite Healthcare Network’s 5th Annual Fire Pitch Competition 

The Fire Pitch Competition is the culmination of Ignite Healthcare Network's annual accelerator program created to encourage innovation in emerging women-led healthcare companies. The accelerator provides opportunities for women entrepreneurs to engage with advisors, potential customers, and investors to accelerate the growth of their companies.

The event is Thursday, March 3, from 5 to 8:30 pm at Texas Medical Center Innovation (2450 Holcombe Blvd.). Click here to register.

March 4 — 3rd Annual Houston Business Matchmaker

Hosted by the SBA, this annual Business Matchmaking event serves as a powerful means to help small businesses grow by meeting with multiple buyers from large businesses, colleges & universities, local, state, and federal agencies. The optimal outcome is a contract, but at minimum the small business will establish a relationship with an important buyer for future business.

The event is Friday, March 4, from 8:45 am to 3:30 pm, and virtual. Click here to register.

March 7-10 — Agora at CERAWeek

The 40th annual CERAWeek, a week-long event that aims to connect and convene the energy industry, returns to in-person programming this year in downtown Houston. The conference's innovation track, called Agora, has four days of panels, presentations, and networking. Note: InnovationMap has a guide to tapping into Houston innovation at CERAWeek ahead of this year's conference. Click here to read it.

The Agora sessions begin Monday, March 7, and conclude Thursday, March 10. All programming will take place at Hilton Americas-Houston (1600 Lamar St.). Click here to register.

March 8 — Transition on Tap

Transition On Tap is Greentown Labs’ monthly networking event devoted to fostering conversations and connections among the climate and energy transition ecosystem in Houston and beyond, and this one is focused on female founders. Entrepreneurs, investors, students, and friends of climatetech are invited to attend, meet colleagues, discuss solutions, and engage with our growing community.

The event is Tuesday, March 8, at 5 pm at Greentown Houston (4200 San Jacinto St.). Click here to register.

March 10 — Rise to the Top

The Greater Houston Partnership’s Women’s Business Alliance invites you to be part of an energizing conversation featuring outstanding female executives and thought leaders that leave the audience inspired and uplifted at the 11th annual Rise to the Top celebrating International Women's Day. To honor this year's International Women's day theme, #BreakTheBias, a panel of esteemed female leaders will discuss how we can work together to foster diversity, equity and inclusivity in our professional and personal lives. We will also talk mentors and mantras that helped these women rise to the top in their careers.

The event is Thursday, March 10, from 10:30 am to 1:30 pm at Marriott Marquis (1777 Walker St.). Click here to register.

March 10 — MarMo Pitch Competition

The Cannon's MarMo Pitch Competition is a life sciences/biotech-based pitch competition. Five teams will pitch an original tech-centered business idea to a panel of business experts and an audience of entrepreneurs, small business owners, potential investors, students, business and community leaders.

The event is Thursday, March 10, from 4 to 7 pm at The Cannon @ MarMo (2121 Market St.). Click here to register.

March 11-20 — SXSW (in Austin)

After two years of virtual conferences, SXSW is gearing up for in-person programming in Austin this year. The conference traverses film, music, education, and more, including tech and innovation. Plenty of Houston innovators will make the trek west to participate in the activations and networking opportunities. InnovationMap has a guide to tapping into Houston innovation at SXSW ahead of this year's conference. Click here to read it.

SXSW begins Friday, March 11, and conclude Sunday, March 20. All programming will take place in downtown Austin. Click here to register.

March 24 — Future Focus - Sportstech

In partnership with InnovationMap, alliantgroup invites you to an exciting panel discussion on the sportstech industry, where technology is transforming the world of sports. Our conversation will focus on four areas, where multi-billion dollar businesses are emerging seemingly overnight:

  • E-sports
  • Gambling
  • Health/performance
  • Fan engagement

Across these categories, technology is enabling interconnectedness, social interaction, new communities, improved health, subscriber-based business models, software as a service, and new revenue streams.

The event is Thursday, March 24, from 6 to 8 pm at alliantgroup (3009 Post Oak Blvd. Suite 2000.). Click here to register.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings